Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Start for free
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
Vci Global Revises Equity Agreement With 102% Premium Pricing, Enhancing Strategic Flexibility
VCI Global Ltd VCIG.O:VCI GLOBAL REVISES EQUITY AGREEMENT WITH 102% PREMIUM PRICING, ENHANCING STRATEGIC FLEXIBILITYVCI GLOBAL LTD - AMENDS EQUITY LINE AGREEMENT WITH ALUMNI CAPITALVCI GLOBAL LTD - RETAINS RIGHT TO ACCESS $112 MILLION FACILITY
Reuters
Thu, May 22
Linvoseltamab In Combination With Carfilzomib Or Bortezomib Shows Promising Initial Results In Earlier Lines Of Treatment For Relapsed/Refractory Multiple Myeloma
Regeneron Pharmaceuticals Inc REGN.O:LINVOSELTAMAB IN COMBINATION WITH CARFILZOMIB OR BORTEZOMIB SHOWS PROMISING INITIAL RESULTS IN EARLIER LINES OF TREATMENT FOR RELAPSED/REFRACTORY MULTIPLE MYELOMAREGENERON PHARMACEUTICALS INC - 90% OBJECTIVE RESPONSE RATE IN LINVOSELTAMAB AND CARFILZOMIB COMBINAT...
Reuters
Thu, May 22
Astellas And Pfizer's Xtandi™ (Enzalutamide) Shows Long-Term Overall Survival In Metastatic Hormone-Sensitive Prostate Cancer
Astellas Pharma Inc 4503.T:ASTELLAS AND PFIZER'S XTANDI™ (ENZALUTAMIDE) SHOWS LONG-TERM OVERALL SURVIVAL IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCERPFIZER INC - XTANDI PLUS ADT REDUCES RISK OF DEATH BY 30%PFIZER INC - XTANDI PLUS ADT SHOWS 66% FIVE-YEAR SURVIVAL PROBABILITYPFIZER INC - NO NE...
Reuters
Thu, May 22
Novita Highlights Positive Data From Phase 2 Trial Of Np-G2-044 In Patients With Advanced And Metastatic Solid Tumors At 2025 Asco Annual Meeting
NOVITA HIGHLIGHTS POSITIVE DATA FROM PHASE 2 TRIAL OF NP-G2-044 IN PATIENTS WITH ADVANCED AND METASTATIC SOLID TUMORS AT 2025 ASCO ANNUAL MEETINGFurther company coverage: [ ]
Reuters
Thu, May 22
Blink Charging CFO Michael Rama To Leave Blink Effective June 2, 2025 - SEC Filing
May 22 (Reuters) - Blink Charging Co BLNK.O:BLINK CHARGING CO - CFO MICHAEL RAMA TO LEAVE BLINK EFFECTIVE JUNE 2, 2025 - SEC FILINGBLINK CHARGING CO - ROBERT STRAUSS APPOINTED INTERIM CFO EFFECTIVE JUNE 3, 2025 - SEC FILINGSource text: [ID:n0001641172-25-012105]
Reuters
Thu, May 22
FDA FDA And CDC, With State And Local Partners, Investigating Illnesses In Multistate Outbreak Of Salmonella Montevideo Infections - Website
FDA: FDA AND CDC, WITH STATE AND LOCAL PARTNERS, INVESTIGATING ILLNESSES IN MULTISTATE OUTBREAK OF SALMONELLA MONTEVIDEO INFECTIONS - WEBSITEFDA: MULTISTATE OUTBREAK OF SALMONELLA MONTEVIDEO INFECTIONS LINKED TO CUCUMBERS GROWN BY BEDNER GROWERS AND DISTRIBUTED BY FRESH START PRODUCE SALESSource tex...
Reuters
Thu, May 22
Talos Energy Inc Files For Mixed Shelf Size Not Disclosed - SEC Filing
Talos Energy Inc TALO.N:TALOS ENERGY INC FILES FOR MIXED SHELF; SIZE NOT DISCLOSED - SEC FILINGSource text: [ID:n0001193125-25-125143]
Reuters
Thu, May 22
Servotronics - Beaver Hollow Wellness Llc Withdraws Nominees For Servotronics Board, Withdrawal Not Due To Concessions Or Settlement
Servotronics Inc SVT.A:SERVOTRONICS - BEAVER HOLLOW WELLNESS LLC WITHDRAWS NOMINEES FOR SERVOTRONICS BOARD, WITHDRAWAL NOT DUE TO CONCESSIONS OR SETTLEMENT
Reuters
Thu, May 22
Halliburton Co - Declares Q2 2025 Dividend Of $0.17 Per Share
Halliburton Co HAL.N:HALLIBURTON CO - DECLARES Q2 2025 DIVIDEND OF $0.17 PER SHARE
Reuters
Thu, May 22
Atco Ltd. Announces Senior Unsecured Notes Issue
Atco Ltd ACOx.TO:ATCO LTD. ANNOUNCES SENIOR UNSECURED NOTES ISSUEATCO LTD - TO ISSUE $250 MILLION OF 3.878% SENIOR UNSECURED NOTESFurther company coverage: [ACOx.TO]
Reuters
Thu, May 22
FTC drops case over Microsoft's $69 billion Activision Blizzard deal
By Jody Godoy May 22 (Reuters) - The U.S. Federal Trade Commission dropped a case that sought to block Microsoft's MSFT.O $69 billion purchase of "Call of Duty" maker Activision Blizzard, saying on Thursday that pursuing the case against the long-closed deal was not in the public inte...
Reuters
Thu, May 22
EXCLUSIVE-US panel divided over Nippon Steel bid for US Steel but path forward seen, says official
By Alexandra AlperWASHINGTON, May 22 (Reuters) - A powerful national security panel was divided in its recommendation to President Donald Trump on the national security implications of Nippon Steel's 5401.T bid for U.S. Steel X.N, a White House official told Reuters on Thursday. However, a major...
Reuters
Thu, May 22
UK's Johnson Matthey in talks to sell Catalyst Technologies unit
By Sabrina Valle May 21 (Reuters) - Britain's Johnson Matthey JMAT.L confirmed on Wednesday that it is in advanced discussions over a potential sale of its Catalyst Technologies division, in a deal that could be worth more than $2 billion.The London-based company, founded in 1817, has been ex...
Reuters
Thu, May 22
Copart misses third-quarter profit estimates on lower vehicle sales, higher expenses
May 22 (Reuters) - Copart CPRT.O reported third-quarter revenue and net income below Wall Street estimates on Thursday, as weak vehicle sales and higher expenses offset growth in its services segment.Shares of the company, which primarily provides auction services to sell damaged and total-loss vehi...
Reuters
Thu, May 22
Split US Supreme Court blocks taxpayer-funded religious charter school
Conservative Justice Amy Coney Barrett recused in caseOklahoma Catholic dioceses were behind proposed schoolIssue could return to the Supreme Court in the futureBy John Kruzel WASHINGTON, May 22 (Reuters) - A split U.S. Supreme Court on Thursday blocked a bid led by two Catholic dioceses to estab...
Reuters
Thu, May 22
Iovance Announces Five-Year Results Of Amtagvi® (Lifileucel) In Patients With Advanced Melanoma At Asco Annual Meeting
Iovance Biotherapeutics Inc IOVA.O:IOVANCE ANNOUNCES FIVE-YEAR RESULTS OF AMTAGVI® (LIFILEUCEL) IN PATIENTS WITH ADVANCED MELANOMA AT ASCO ANNUAL MEETINGIOVANCE BIOTHERAPEUTICS INC: ONE-TIME AMTAGVI TREATMENT DEMONSTRATED DURABLE RESPONSES AND A FIVE-YEAR OVERALL SURVIVAL RATE OF 20%
Reuters
Thu, May 22
Fast Track Group Announces Pricing Of $15 Million Initial Public Offering
FAST TRACK GROUP ANNOUNCES PRICING OF $15 MILLION INITIAL PUBLIC OFFERINGFAST TRACK GROUP: PRICING OF INITIAL PUBLIC OFFERING AT $4.00 PER SHAREFurther company coverage: [ ]
Reuters
Thu, May 22
Merus’ Petosemtamab With Pembrolizumab Interim Data Demonstrates Robust Efficacy And Durability In 1L Pd-L1+ R/M Hnscc
Merus NV 2GH.F:MERUS’ PETOSEMTAMAB WITH PEMBROLIZUMAB INTERIM DATA DEMONSTRATES ROBUST EFFICACY AND DURABILITY IN 1L PD-L1+ R/M HNSCC
Reuters
Thu, May 22
Column: Blake Lively, Justin Baldoni and the court of public opinion
By Jenna Greene May 22 (Reuters) - For lawyers, there’s a fine art to litigating in the press, of calibrating how to shape a public narrative without running afoul of ethics rules or antagonizing judges.It can be a thin line – and it’s being tested by counsel in bitter litigation between actor-di...
Reuters
Thu, May 22
Ackman's hedge fund Pershing Square bets on Amazon, exits Canadian Pacific
By Svea Herbst-BaylissNEW YORK, May 22 (Reuters) - Billionaire investor Bill Ackman told clients on Thursday that his hedge fund bought Amazon shares last month, betting earnings will continue to grow at the online retailer as President Donald Trump's tariffs bite less than consumers initially f...
Reuters
Thu, May 22
1
...
296
297
298
299
300
next page
KeyAI
Please log in to use KeyAI
Log in
Start for free